Breaking News

Mutating strains stay one step ahead of vacccine-makers
Report summarizes risk factors, screening for major cancer sites
Findings challenge existing recommendations

Recent Headlines

Serious, potentially fatal allergic reactions can occur
‘Humiliating’ garment may soon be out of style

FEATURED STORIES FROM P&T MARCH 2015

The number of cancer medications approved by the Food and Drug Administration has risen steadily in recent years. This article provides a concise overview of drugs and indications added to the cancer armamentarium in 2014 and to date in 2015.
Taylor Butler PharmD
Stacey Maravent PharmD
Jennifer Boisselle
Jose Valdes PharmD
Prescription: Washington
Sandoz’s Filgrastim Faces Naming and Court Hurdles
As first biosimilar approval nears, key questions remain.
Stephen Barlas